Ironwood Pharmaceuticals | IRWD - Market Capitalization


Ironwood Pharmaceuticals reported $654.3M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.53B 199M Aug/2026
Akebia Therapeutics USD 427M 297M Dec/2025
Almirall EUR 2.76B 472.53M Dec/2025
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amarin USD 290M 51M Dec/2025
Ardelyx USD 1.48B 63M Mar/2026
Astellas Pharma JPY 4.1T 160.64B Aug/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
Charles River Laboratories USD 13.33B 2.94B Aug/2026
Coherus Biosciences USD 172M 19M Dec/2025
Emergent BioSolutions USD 125M 51M Dec/2023
Halozyme Therapeutics USD 10.91B 1.63B Aug/2026
Incyte USD 26.84B 4.19B Aug/2026
Karyopharm Therapeutics USD 221M 95M Aug/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
MacroGenics USD 184M 82M Mar/2026
Pacira USD 1.28B 286M Aug/2026
Sarepta Therapeutics USD 1.5B 402M Aug/2026
Takeda JPY 8.2T 809.7B Jun/2026
Ultragenyx Pharmaceutical USD 2.12B 1.16B Aug/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024